Horrell Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Horrell Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-200	Closed	-$14K	–	184
2015 Q4	$14K	Hold	200	–	–	0.01%	121
2015 Q3	$12K	Hold	200	–	–	0.01%	141
2015 Q2	$13K	Hold	200	–	–	0.01%	149
2015 Q1	$13K	Hold	200	–	–	0.01%	243
2014 Q4	$12K	Hold	200	–	–	0.01%	244
2014 Q3	$10K	Hold	200	–	–	﹤0.01%	244
2014 Q2	$10K	Hold	200	–	–	﹤0.01%	247
2014 Q1	$10K	Hold	200	–	–	0.01%	234
2013 Q4	$11K	Hold	200	–	–	0.01%	227
2013 Q3	$9K	Sell	200 -215	-52%	-$9.44K	﹤0.01%	225
2013 Q2	$19K	Buy	+415	New	+$18K	0.01%	207

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Horrell Capital Management's BMY Position: Q1 2016 in Review

Horrell Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2016, closing a stake of 200 shares — an estimated $14K sold.

Horrell Capital Management first reported a position in BMY in Q2 2013 and held it in 11 quarters. The position peaked at $19K in Q2 2013. 1,523 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

Horrell Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2016 after selling out during the quarter.
Horrell Capital Management sold 200 Bristol-Myers Squibb shares in Q1 2016, an estimated $14K.
Horrell Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 11 quarters.
Horrell Capital Management's Bristol-Myers Squibb position peaked at $19K in Q2 2013.
1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on Horrell Capital Management's 13F filing for Q1 2016, filed 21 Apr 2016.